Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Oxalobacter formigenes is effective at lowering
urinary oxalate levels in patients with primary hyperoxaluria.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
OxThera
Collaborator:
FP7-SME-2013 Research for the benefit of SMEs program